Aarti Drugs Ltd (AARTIDRUGS) — Announcement | 29 September 2026
Aarti Drugs Ltd announced that its trading window will close on October 1, 2026, remaining shut for 48 hours after the quarter and half-year financial results for September 30, 2026 are declared, restricting insider trading during this period.
About Aarti Drugs Ltd (AARTIDRUGS)
Healthcare · Pharmaceuticals · Listed on BSE
📡 Get AI alerts when AARTIDRUGS files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track AARTIDRUGS — Free💡 Ask AI about this filing
📊 More AARTIDRUGS filings
- 🟡 Board Meeting — 26 September 2026Aarti Drugs announced board changes at its September 26, 2026 AGM: Uday Patil retired as Whole-time ...
- 🟡 Voting Results — 26 September 2026At the 41st AGM on September 26, 2026, shareholders approved all 16 resolutions with overwhelming ma...
- 🟡 Board Meeting — 26 September 2026Aarti Drugs reported consolidated revenue of Rs. 2,568 crores for FY26, up 7% from Rs. 2,403 crores ...
- 🟡 Board Meeting — 26 September 2026Aarti Drugs held its 41st AGM on September 26, 2026 via video conference with 93 shareholders presen...
- 🟡 Board Meeting — 2 September 2026No summary available
🔥 Also filed on 29 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when AARTIDRUGS files new disclosures
Track AARTIDRUGS filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track AARTIDRUGS — FreeFree account · 2 AI queries/day